NCT05635929View on ClinicalTrials.gov

Oral Mucositis and Quality of Life With a Mucosa Topical Composition in Head & Neck Cancer Patients.

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

October 11, 2022

Primary Completion Date

June 28, 2023

Study Completion Date

September 11, 2023

Conditions
Oral MucositisQuality of LifeMucositisPainSpeechSalivaRadiation ToxicityChemotherapeutic Toxicity
Interventions
COMBINATION_PRODUCT

Composition comprising olive oil, xylitol and betaine

Topical composition in the form of a gel.

Trial Locations (1)

28023

Mucosa Innovations S.L., Madrid

Sponsors
All Listed Sponsors
lead

Mucosa Innovations, S.L.

INDUSTRY

NCT05635929 - Oral Mucositis and Quality of Life With a Mucosa Topical Composition in Head & Neck Cancer Patients. | Biotech Hunter | Biotech Hunter